{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:49:47Z","timestamp":1790308187324,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>There is interest in the role of peripheral interleukin-6 (IL-6) in depression and the effect of treatment (e. g., pharmacologic, psychosocial, neurostimulation). However, the relationship between cognitive behavioral therapy (CBT), IL-6 and depression has not yet been established. We conducted a meta-analysis to explore the association between CBT and change of peripheral IL-6 levels in depressive symptoms or major depressive disorder (MDD). A systematic search of online databases (i.e., PubMed, Web of Science, Google Scholar, PsycINFO, and Cochrane Library) was completed from inception to May 2021. In total, 10 eligible papers with 940 participants reporting peripheral IL-6 levels before and after CBT were included in the analysis. The main result indicates that peripheral levels of IL-6 were significantly lower after CBT intervention in individuals with depression, with a small effect (SMD = 0.38, 95% CI: 0.07, 0.69, <jats:italic>p<\/jats:italic> = 0.02). The results of subgroup analyses demonstrate that (1) there was a significant decrease in IL-6 for studies that were equal to or &amp;lt;8 weeks in duration vs. more than 8 weeks in duration, and (2) IL-6 was significantly reduced in the Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnosis (i.e., DSM-IV, DSM-IV-TR, or DSM-V) of MDD, but not for the subgroup without DSM diagnosis. Publication year was identified as a potential contributor to heterogeneity of the results from our analysis. Taken together, our findings support the notion that CBT influences peripheral IL-6 in individuals with depression and represents a point of commonality with other antidepressant treatment modalities (e.g., antidepressants).<\/jats:p><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:ext-link>https:\/\/doi.org\/10.17605\/osf.io\/tr9yh<\/jats:ext-link>, identifier: 10.17605\/osf.io\/tr9yh.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2022.844176","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T06:21:38Z","timestamp":1652422898000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Haijing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla M.","family":"Teopiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","article-title":"Depression, chronic diseases, and decrements in health: results from the World Health Surveys","volume":"370","author":"Moussavi","year":"2007","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","article-title":"The bidirectional relationship of depression and inflammation: double trouble","volume":"107","author":"Beurel","year":"2020","journal-title":"Neuron."},{"key":"B3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","article-title":"Inflamed moods: a review of the interactions between inflammation and mood disorders","volume":"53","author":"Rosenblat","year":"2014","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.3390\/nu12103019","article-title":"C-reactive protein as a possible predictor of trail-making performance in Individuals with psychiatric disorders","volume":"12","author":"Dalkner","year":"2020","journal-title":"Nutrients."},{"key":"B6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/2045125318791944","article-title":"Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression","volume":"8","author":"Lee","year":"2018","journal-title":"Therap Adv Psychopharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.12788\/acp.0034","article-title":"Examining the association between inflammation and motivational anhedonia in neuropsychiatric disorders: a systematic review","volume":"33","author":"Nogo","year":"2021","journal-title":"Ann Clin Psychiatry."},{"key":"B8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.bbi.2007.01.010","article-title":"Depressive disorders and immunity: 20 years of progress and discovery","volume":"21","author":"Irwin","year":"2007","journal-title":"Brain Behav Immun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.rcp.2017.03.002","article-title":"Pro-inflammatory cytokines, biomarkers, genetics and the immune system: a mechanistic approach of depression and psoriasis","volume":"47","author":"Aleem","year":"2018","journal-title":"Rev Colomb Psiquiatr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.jpsychires.2020.12.029","article-title":"Relationships between inflammatory markers and suicide risk status in major depression","volume":"87","author":"Ganan\u00e7a","year":"2021","journal-title":"Biol Psychiatry."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1038\/s41380-020-00867-4","article-title":"The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression","volume":"26","author":"Mac Giollabhui","year":"2020","journal-title":"Mol Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"573594","DOI":"10.1155\/2010\/573594","article-title":"Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males","volume":"2010","author":"Chen","year":"2010","journal-title":"Mediators Inflamm."},{"key":"B13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatr Scand."},{"key":"B14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.exger.2017.12.005","article-title":"The association between C-reactive protein, Interleukin-6 and depression among older adults in the community: a systematic review and meta-analysis","volume":"102","author":"Smith","year":"2018","journal-title":"Exp Gerontol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuron.2009.09.002","article-title":"Cytokines and CNS development","volume":"64","author":"Deverman","year":"2009","journal-title":"Neuron."},{"key":"B16","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.tins.2012.08.001","article-title":"Major histocompatibility complex class I proteins in brain development and plasticity","volume":"35","author":"Elmer","year":"2012","journal-title":"Trends Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","article-title":"The complement system: an unexpected role in synaptic pruning during development and disease","volume":"35","author":"Stephan","year":"2012","journal-title":"Annu Rev Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1136\/bmj.314.7097.1811","article-title":"Fortnightly review: cognitive behaviour therapy clinical applications","volume":"314","author":"Enright","year":"1997","journal-title":"BMJ."},{"key":"B20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/978-981-10-5562-1_16","article-title":"Cognitive-behavioral therapy","volume":"1010","author":"He","year":"2017","journal-title":"Advances in Experimental Medicine and Biology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1176\/appi.ajp.160.5.825","article-title":"Cognitive Behavior therapy for depression? Choose horses for courses","volume":"160","author":"Parker","year":"2003","journal-title":"Am J Psychiatry."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/jamapsychiatry.2020.0431","article-title":"psychosocial interventions and immune system function: a systematic review and meta-analysis of randomized clinical trials","volume":"77","author":"Shields","year":"2020","journal-title":"JAMA Psychiatry."},{"key":"B23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jneuroim.2015.06.004","article-title":"The effect of proinflammatory cytokines in cognitive behavioral therapy","volume":"285","author":"Moreira","year":"2015","journal-title":"J Neuroimmunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0004867417701996","article-title":"Cognitive behaviour therapy and inflammation: a systematic review of its relationship and the potential implications for the treatment of depression","volume":"51","author":"Lopresti","year":"2017","journal-title":"Austr N Z J Psychiatry."},{"key":"B25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jad.2018.05.008","article-title":"Leptin and adiponectin levels in major depressive disorder: a systematic review and meta-analysis","volume":"238","author":"Cao","year":"2018","journal-title":"J Affect Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ."},{"key":"B27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4236\/ojpsych.2015.53028","article-title":"Effects of religious vs. conventional cognitive-behavioral therapy on inflammatory markers and stress hormones in major depression and chronic medical illness: a randomized clinical trial","volume":"5","author":"Berk","year":"2015","journal-title":"Open J Psychiatry."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1132","DOI":"10.1038\/tp.2017.76","article-title":"Immunological effects of behavioral activation with exercise in major depression: an exploratory randomized controlled trial","volume":"7","author":"Euteneuer","year":"2017","journal-title":"Transl Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.psychres.2013.03.002","article-title":"The impact of cognitive behavioral therapy on IL-6 levels in unmedicated women experiencing the first episode of depression: a pilot study","volume":"209","author":"Gazal","year":"2013","journal-title":"Psychiatry Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2337\/dc14-1416","article-title":"The effect of a diabetes-specific cognitive behavioral treatment program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trial","volume":"38","author":"Hermanns","year":"2015","journal-title":"Diabetes Care."},{"key":"B31","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/gps.2371","article-title":"Effects of a cognitive-behavioral group program for community-dwelling elderly with minor depression","volume":"25","author":"Hsu","year":"2010","journal-title":"Int J Geriatr Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbi.2014.03.020","article-title":"Expression of Toll-Like Receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder","volume":"40","author":"K\u00e9ri","year":"2014","journal-title":"Brain Behav Immun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s10865-016-9769-z","article-title":"Low-grade inflammation may moderate the effect of behavioral treatment for chronic pain in adults","volume":"39","author":"Lasselin","year":"2016","journal-title":"J Behav Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.brat.2013.07.005","article-title":"A randomized clinical trial of behavioral activation (BA) therapy for improving psychological and physical health in dementia caregivers: results of the pleasant events program (PEP)","volume":"51","author":"Moore","year":"2013","journal-title":"Behav Res Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1037\/0022-006X.76.3.408","article-title":"Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression","volume":"76","author":"Zautra","year":"2008","journal-title":"J Consult Clin Psychol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1056\/NEJMcpc1609309","article-title":"Case 30-2016","volume":"375","author":"Irwin","year":"2016","journal-title":"N Engl J Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"E240","DOI":"10.1188\/11.ONF.E240-E252","article-title":"Dose effects of relaxation practice on immune responses in women newly diagnosed with breast cancer: an exploratory study","volume":"38","author":"Kang","year":"2011","journal-title":"Oncol Nurs Forum."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.bbi.2015.06.078","article-title":"Good moments add up for inflammatory health: associations of momentary positive events with inflammatory state and responsiveness","volume":"45","author":"Sin","year":"2015","journal-title":"Brain Behav Immun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.31887\/DCNS.2017.19.1\/rmcintyre","article-title":"Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders","volume":"19","author":"Subramaniapillai","year":"2017","journal-title":"Dialog Clin Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.bbi.2012.06.001","article-title":"A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity","volume":"26","author":"Hiles","year":"2012","journal-title":"Brain Behav Immun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s004060170058","article-title":"Different immune patterns in melancholic and non-melancholic major depression","volume":"251","author":"Rothermundt","year":"2001","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2012.11.009","article-title":"Melancholic and atypical major depression - connection between cytokines, psychopathology and treatment","volume":"43","author":"Dunjic-Kostic","year":"2013","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry."},{"key":"B43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005110-200501000-00004","article-title":"An overview of public policy and the nursing shortage","volume":"35","author":"Kaestner","year":"2005","journal-title":"J Nurs Administr."},{"key":"B44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000329556","article-title":"Serum testosterone concentration in combat-related chronic posttraumatic stress disorder","volume":"65","author":"Karlovi\u0107","year":"2012","journal-title":"Neuropsychobiology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","article-title":"Cytokine production and treatment response in major depressive disorder","volume":"22","author":"Lanquillon","year":"2000","journal-title":"Neuropsychopharmacology."},{"key":"B46","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.pnpbp.2009.03.020","article-title":"Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression","volume":"33","author":"Yoshimura","year":"2009","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry."},{"key":"B47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0165-1781(93)90027-E","article-title":"Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pitu-itary-adrenal axis in severe depression","volume":"49","author":"Maes","year":"1993","journal-title":"Psychiatry Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/09540260903344107","article-title":"The building blocks of treatment in cognitive-behavioral therapy","volume":"46","author":"Huppert","year":"2009","journal-title":"Isr J Psychiatry Relat Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/ndt\/gfq411","article-title":"Serum IL-6, albumin and comorbidities are closely correlated with symptoms of depression in patients on maintenance haemodialysis","volume":"26","author":"Hung","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"B50","doi-asserted-by":"publisher","first-page":"S156","DOI":"10.1016\/j.biopsych.2021.02.401","article-title":"Peripheral inflammatory biomarkers define biotypes of bipolar depression","volume":"89","author":"Lee","year":"2021","journal-title":"Biol Psychiatry."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.844176\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T06:21:41Z","timestamp":1652422901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.844176\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":50,"alternative-id":["10.3389\/fpsyt.2022.844176"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.844176","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"article-number":"844176"}}